By Joanne Chiu

JD Health International Inc., an online health-care business controlled by Chinese online retailing giant JD.com Inc., plans to close the book for its international offer on Monday, a day ahead of schedule.

The Beijing-based company has received overwhelming demand from institutional investors for its up to US$3.5 billion initial public offering in Hong Kong, according to sources familiar with the situation. One person said the company will likely price the deal at the upper half of an indicative price range, but no pricing guidance is available for now.

The company is taking orders for a smaller portion of the Hong Kong deal reserved for individual investors till noon, Tuesday.

JD Health runs China's largest online pharmacy by revenue, organizes medical bookings and offers online consultations with doctors. It is offering 381.9 million shares at an indicative price range of HK$62.80 (US$8.10) to HK$70.58 each, raising as much as US$3.5 billion ahead of a market debut on Dec. 8. The deal size could increase to up to US$4 billion if underwriting banks exercise an option to buy 15% more stock.

Write to Joanne Chiu at Joanne.chiu@wsj.com 


-0-

Write to Singapore Editors at singaporeeditors@dowjones.com

(END) Dow Jones Newswires

11-29-20 2315ET